Mark works as a quantitative developer and researcher and is responsible for developing and maintaining Osmosis’ quantitative research systems and models as well as conducting alpha-signal research. Mark is a highly experienced quantitative researcher and portfolio manager, having spent 14 years at GMO, four as a quant analyst and ten as a portfolio manager. During this time, he created and managed various funds including the GMO Quality and GMO Tactical Opportunities Funds. He was also Head of the Emerging Equities Quant Team for four years.
Mark gained his Master in Mathematics from Oxford University and is a CFA* charter holder. Mark also serves as an external adviser to Kidney Research UK, the UK’s largest funder of kidney research.
IMPORTANT INFORMATION:
Global Investors (ex US and Australia). This document is issued in the UK by Osmosis Investment Management UK Limited (“Osmosis”). Osmosis is authorised and regulated by the Financial Conduct Authority “FCA” with FRN 765056. This document is a “financial promotion” within the scope of the rules of the FCA. In the United Kingdom, the issue or distribution of this document is being made only to and directed only at professional clients (as defined in the rules of the FCA) (“Professional Clients”). This document must not be acted or relied upon by persons who are not Professional Clients. Any investment or investment activity to which this document relates is available only to Professional Clients and will be engaged in only with Professional Clients.
US Investors. This document is issued by Osmosis Investment Management US LLC (“Osmosis”). Osmosis Investment Management UK Limited (“Osmosis UK”) is an affiliate of Osmosis and has been operating the Osmosis Model of Resource Efficiency. Osmosis UK is regulated by the FCA. Osmosis and Osmosis UK are both wholly owned by Osmosis (Holdings) Limited (“OHL”).
Australia Investors: This document is issued in Australia by Osmosis Investment Management (Australia) Pty Ltd (ABN 80 670 854 798, CAR No. 001305635) is a corporate authorised representative of Eminence Global Asset Management Pty Ltd which is the holder of an Australian Financial Services Licence (AFS Licence No. 305573). Osmosis Investment Management (Australia) Pty Ltd) is a member of the Osmosis group of companies, the parent company being Osmosis (Holdings) Limited a UK company headquartered in London.
© 2009 – 2024 OSMOSIS INVESTMENT MANAGEMENT
This site is designed for professional investors only.
Please allow 48 business hours for your registration to be approved
Once a month, we curate the best of our insights for our subscribers. Sign up to our newsletter here.
